CR10798A - Terapia de combinacion en secuencia - Google Patents
Terapia de combinacion en secuenciaInfo
- Publication number
- CR10798A CR10798A CR10798A CR10798A CR10798A CR 10798 A CR10798 A CR 10798A CR 10798 A CR10798 A CR 10798A CR 10798 A CR10798 A CR 10798A CR 10798 A CR10798 A CR 10798A
- Authority
- CR
- Costa Rica
- Prior art keywords
- combination therapy
- sequence combination
- angiogenesis
- disorders related
- administration
- Prior art date
Links
- 238000002648 combination therapy Methods 0.000 title 1
- 230000033115 angiogenesis Effects 0.000 abstract 2
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 abstract 1
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 239000011230 binding agent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Microbiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Mycology (AREA)
- Cardiology (AREA)
- Ophthalmology & Optometry (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Vascular Medicine (AREA)
- Reproductive Health (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Transplantation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Abstract
Se divulgan nuevos metodos de tratamiento de trastornos relacionados con la angiogenesis. Los trastornos relacionados con la angiogenesis se tratan por la administracion de un agente de union al ectodominio Tiel y de una gente antagonista de VEGF.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US85226306P | 2006-10-17 | 2006-10-17 | |
US87573606P | 2006-12-19 | 2006-12-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
CR10798A true CR10798A (es) | 2009-06-09 |
Family
ID=39314809
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CR10798A CR10798A (es) | 2006-10-17 | 2009-05-15 | Terapia de combinacion en secuencia |
Country Status (17)
Country | Link |
---|---|
US (1) | US20080160019A1 (es) |
EP (1) | EP2073826A4 (es) |
JP (1) | JP2010506951A (es) |
KR (1) | KR20090067214A (es) |
AU (1) | AU2007311092A1 (es) |
BR (1) | BRPI0717760A2 (es) |
CA (1) | CA2666714A1 (es) |
CR (1) | CR10798A (es) |
EA (1) | EA200900562A1 (es) |
EC (1) | ECSP099336A (es) |
IL (1) | IL198026A0 (es) |
MA (1) | MA30901B1 (es) |
MX (1) | MX2009004070A (es) |
NI (1) | NI200900057A (es) |
NO (1) | NO20091375L (es) |
TN (1) | TN2009000136A1 (es) |
WO (1) | WO2008048996A2 (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007528720A (ja) * | 2003-08-12 | 2007-10-18 | ダイアックス コーポレイション | Tie1結合リガンド |
WO2005107461A2 (en) * | 2004-04-07 | 2005-11-17 | The General Hospital Corporation | Modulating lymphatic function |
WO2008089070A2 (en) * | 2007-01-12 | 2008-07-24 | Dyax Corp. | Combination therapy for the treatment of cancer |
EP2156834A1 (en) * | 2008-08-08 | 2010-02-24 | S.I.F.I - Società Industria Farmaceutica Italiana - S.P.A. | Ophthalmic pharmaceutical compositions comprising Sorafenib for the treatment of neoangiogenic pathologies of the eye |
US20130028920A1 (en) * | 2010-03-31 | 2013-01-31 | Universite De Geneve | Stabilized antibody preparations and uses thereof |
US20150003204A1 (en) * | 2013-06-27 | 2015-01-01 | Elwha Llc | Tactile feedback in a two or three dimensional airspace |
US9804675B2 (en) | 2013-06-27 | 2017-10-31 | Elwha Llc | Tactile feedback generated by non-linear interaction of surface acoustic waves |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4926320B2 (ja) * | 1999-04-28 | 2012-05-09 | ボード・オブ・リージエンツ,ザ・ユニバーシテイ・オブ・テキサス・システム | Vegfの選択的阻害による癌処置のための組成物および方法 |
US20040132675A1 (en) * | 2002-02-08 | 2004-07-08 | Calvin Kuo | Method for treating cancer and increasing hematocrit levels |
JP2007528720A (ja) * | 2003-08-12 | 2007-10-18 | ダイアックス コーポレイション | Tie1結合リガンド |
US7871610B2 (en) * | 2003-08-12 | 2011-01-18 | Dyax Corp. | Antibodies to Tie1 ectodomain |
US7485297B2 (en) * | 2003-08-12 | 2009-02-03 | Dyax Corp. | Method of inhibition of vascular development using an antibody |
WO2006020706A2 (en) * | 2004-08-12 | 2006-02-23 | Dyax Corp. | Tie complex binding proteins |
WO2008089070A2 (en) * | 2007-01-12 | 2008-07-24 | Dyax Corp. | Combination therapy for the treatment of cancer |
-
2007
- 2007-10-17 MX MX2009004070A patent/MX2009004070A/es unknown
- 2007-10-17 US US11/873,856 patent/US20080160019A1/en not_active Abandoned
- 2007-10-17 BR BRPI0717760-7A2A patent/BRPI0717760A2/pt not_active IP Right Cessation
- 2007-10-17 EP EP07854125A patent/EP2073826A4/en not_active Withdrawn
- 2007-10-17 CA CA002666714A patent/CA2666714A1/en not_active Abandoned
- 2007-10-17 AU AU2007311092A patent/AU2007311092A1/en not_active Abandoned
- 2007-10-17 JP JP2009533500A patent/JP2010506951A/ja not_active Withdrawn
- 2007-10-17 EA EA200900562A patent/EA200900562A1/ru unknown
- 2007-10-17 WO PCT/US2007/081621 patent/WO2008048996A2/en active Application Filing
- 2007-10-17 KR KR1020097009954A patent/KR20090067214A/ko not_active Application Discontinuation
-
2009
- 2009-03-31 NO NO20091375A patent/NO20091375L/no not_active Application Discontinuation
- 2009-04-06 IL IL198026A patent/IL198026A0/en unknown
- 2009-04-13 TN TNP2009000136A patent/TN2009000136A1/fr unknown
- 2009-04-16 NI NI200900057A patent/NI200900057A/es unknown
- 2009-05-14 MA MA31888A patent/MA30901B1/fr unknown
- 2009-05-15 EC EC2009009336A patent/ECSP099336A/es unknown
- 2009-05-15 CR CR10798A patent/CR10798A/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP2073826A4 (en) | 2010-12-15 |
US20080160019A1 (en) | 2008-07-03 |
MA30901B1 (fr) | 2009-11-02 |
AU2007311092A1 (en) | 2008-04-24 |
MX2009004070A (es) | 2009-04-27 |
IL198026A0 (en) | 2011-08-01 |
WO2008048996A2 (en) | 2008-04-24 |
BRPI0717760A2 (pt) | 2013-11-12 |
JP2010506951A (ja) | 2010-03-04 |
KR20090067214A (ko) | 2009-06-24 |
TN2009000136A1 (en) | 2010-10-18 |
WO2008048996A3 (en) | 2008-07-03 |
EP2073826A2 (en) | 2009-07-01 |
EA200900562A1 (ru) | 2009-10-30 |
WO2008048996A9 (en) | 2008-09-12 |
NO20091375L (no) | 2009-07-10 |
CA2666714A1 (en) | 2008-04-24 |
NI200900057A (es) | 2010-02-02 |
ECSP099336A (es) | 2009-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CR10798A (es) | Terapia de combinacion en secuencia | |
NO20054371L (no) | Somatostatin-dopamin kimaere analoger | |
HK1139930A1 (en) | Cyclopamine lactam analogs and methods of use thereof | |
MX2009009428A (es) | Analogos de ciclopamina heterociclicos y metodos de uso de los mismos. | |
MA32161B1 (fr) | Formes de rifaximine et utilisations de celles-ci | |
EA201000914A1 (ru) | Новые терапевтические подходы в лечении смт и связанных с ней расстройств | |
RS54156B1 (en) | COMBINED THERAPY INCLUDING ALFA5BETA1 ANTAGONISTS | |
MY173994A (en) | Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same | |
CY1111622T1 (el) | Ανθρωποποιημενοι ανταγωνιστες anti-cmet | |
EA201170592A1 (ru) | Комбинированная терапия с применением пептид эпоксикетонов | |
DK2167117T3 (da) | Anvendelse af VWF-stabiliserede FVIII-præparater til ekstravaskulær administration til terapeutisk og profylaktisk behandling af blødningsforstyrrelser | |
UA109658C2 (xx) | Антитіло проти cgrp | |
RS52102B (en) | PIRPHENIDONE THERAPY Avoiding FLUVOXAMINE | |
NZ584042A (en) | Use of mva to treat prostate cancer | |
EA200900091A1 (ru) | Новые показания к применению прямых ингибиторов тромбина в лечении сердечно-сосудистых заболеваний | |
EA201070609A1 (ru) | Способы лечения ожирения и ассоциированных с ожирением заболеваний и расстройств | |
CY1114023T1 (el) | Διυποκατεστημενης φθαλαζινης ανταγωνιστες σηματοδοτικης οδου hedgehog | |
CR8850A (es) | Composicion y metodo para tratar hemorroides y/o transtornos ano-rectales | |
CR10997A (es) | Metodo de tratamiento de canceres | |
CY1110369T1 (el) | Νεος συνεργιστικος συνδυασμος ο οποιος περιεχει ροφλουμιλαστη και φορμοτερολη | |
MY164998A (en) | Isoquinolinone derivatives as nk3 antagonists | |
WO2007033140A3 (en) | Prok2 antagonists and methods of use | |
EA201070637A1 (ru) | Соединения циклоалкилокси- и гетероциклоалкилоксипиридина как модуляторы гистаминового рецептора н | |
EA200970816A1 (ru) | Новая лекарственная форма | |
CL2007000554A1 (es) | Metodo para diagnosticar matastasis en el nodulo linfatico de un carcinoma gastrico; y metodo para determinar o ajustar una terapia para un paciente con carcinoma gastrico. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal (granting procedure) |